Back
32
Day Range
$15.35
$15.35
52-Week Range
$9.01
$15.47
Volume
100
50D / 200D Avg
$14.96
/
$12.80
Prev Close
$15.47
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 71.3 | 14.0 |
| P/B | 2.2 | 2.4 |
| ROE % | 3.1 | 11.4 |
| Net Margin % | 4.2 | 10.1 |
| Rev Growth 5Y % | 7.6 | 7.0 |
| D/E | 0.2 | 0.5 |
Key Takeaways
Revenue grew 7.57% annually over 5 years — modest growth
Earnings grew 355.14% over the past year
ROE of 3.10% is below average
Debt/Equity of 0.23 — conservative balance sheet
Generating 134.24M in free cash flow
P/E of 71.34 — premium valuation
Growth
Revenue Growth (5Y)
7.57%
Revenue (1Y)12.37%
Earnings (1Y)355.14%
FCF Growth (3Y)N/A
Quality
Return on Equity
3.10%
ROIC2.77%
Net Margin4.17%
Op. Margin6.11%
Safety
Debt / Equity
0.23
Current Ratio2.04
Interest Coverage3.79
Valuation
P/E Ratio
71.34
P/B Ratio2.22
EV/EBITDA48.75
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.37% | Revenue Growth (3Y) | 11.28% |
| Earnings Growth (1Y) | 355.14% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7.57% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.11B | Net Income (TTM) | 46.18M |
| ROE | 3.10% | ROA | 1.98% |
| Gross Margin | 41.21% | Operating Margin | 6.11% |
| Net Margin | 4.17% | Free Cash Flow (TTM) | 134.24M |
| ROIC | 2.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.23 | Current Ratio | 2.04 |
| Interest Coverage | 3.79 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 71.34 | P/B Ratio | 2.22 |
| P/S Ratio | 2.97 | PEG Ratio | 0.16 |
| EV/EBITDA | 48.75 | Dividend Yield | 0.01% |
| Market Cap | 3.29B | Enterprise Value | 3.30B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.11B | 985.72M | 894.52M | 863.25M | 827.20M |
| Net Income | 46.18M | 10.15M | -38.47M | 4.28M | -40.86M |
| EPS (Diluted) | 0.21 | 0.05 | -0.20 | 0.02 | -0.23 |
| Gross Profit | 456.47M | 767.68M | 682.04M | 680.78M | 655.61M |
| Operating Income | 67.69M | 36.09M | -5.26M | 46.87M | 5.75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.34B | 2.40B | 2.37B | 2.15B | 2.14B |
| Total Liabilities | 829.43M | 908.28M | 911.59M | 828.98M | 855.71M |
| Shareholders' Equity | 1.49B | 1.49B | 1.46B | 1.32B | 1.29B |
| Total Debt | 342.86M | 408.81M | 403.25M | 403.88M | 396.11M |
| Cash & Equivalents | 337.64M | 377.10M | 387.95M | 248.38M | 206.49M |
| Current Assets | 713.72M | 741.14M | 718.66M | 552.72M | 499.27M |
| Current Liabilities | 350.51M | 353.42M | 351.08M | 274.61M | 280.99M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#776 of 1018
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026